SMYD3 and colorectal carcinoma: Immunoprecipitation of whole-cell lysates with an antiserum against SMYD3 or mTOR, followed by immunoblotting, revealed that SMYD3 is a molecular partner of mTOR in CRC cells (Figs. 3A, 4).